Artwork
iconShare
 
Manage episode 516141076 series 3610151
Content provided by TopHealth Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TopHealth Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Welcome back to Health Unlocked! In today’s episode, Jasen Petersen explores a fascinating and refreshingly practical side of health innovation: how medical devices like IBAL are rewriting the rules of bringing new interventions to market. If you’ve ever wondered why some health-supporting products aren’t classified as drugs or supplements, or how the FDA draws that crucial line, you’ll love this discussion.

Jasen, speaking from both professional and personal experience (post-lithotripsy, no less - ouch!), walks us through the surprising world of medical device regulation. He explains why IBAL, a micronutrient matrix designed to restore foundational cellular health, qualifies as a medical device rather than a drug and why that distinction could make innovative treatments far more accessible, affordable, and fast to reach those who need them most.

Along the way, you’ll hear about strange regulatory quirks (like how toothpaste can be a cosmetic, a drug, or a device!), learn what it truly means for something to have a “PMI mechanism,” and get a behind-the-scenes look at how shifting the regulatory path from drugs to devices could transform healthcare innovation for both patients and investors.

By the end, you’ll have a whole new appreciation for how creative science, regulatory strategy, and a bit of bold thinking can work together to unlock better health for everyone. Let’s dive in!

Timestamps:

00:00 "IBAL: Redefining Medical Regulations"

04:23 "Foundations of Immune Healing"

08:50 Drug vs. Device Development Timelines

11:01 Drug vs Device Development Differences

15:20 Biotech Confidence in Non-PMI Drugs

20:01 IBAL Ingestion Risks and Alternatives

23:30 "Possibilities for Medical Innovation"

27:43 "Medical Device Outperforming Drugs"

28:48 Drug vs. Device Approval Risks

32:46 "Ion Gel Medical Device Approval"

36:07 Tokenized Research for Immune Continuum

39:26 "Grateful Acknowledgment"

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/
Ionic Alliance Foundation Website - https://iaf.care/
Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/
TopHealth Media Website - https://tophealth.care/

  continue reading

17 episodes